Publications
Scientific publications arising from COVID-NMA Initiative
- Interleukin‐1 blocking agents for treating COVID‐19 (Davidson, Menon et al, Cochrane Library, 2021)
Read this article - Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review (Ghosn L et al, Cochrane Library, 2021)
Read this article - The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic (Boutron I et al. Annals Intern Med 2020)
Read this article - Research response to COVID-19 needed better coordination and collaboration: a living mapping of registered trials (Nguyen et al. J Clin Epidemiol 2020)
Read this article - Day-to-day discovery of preprint-publication links (Cabanac G et al, Scientometrics)
Read this article - Transparency and reporting characteristics of COVID-19 randomized controlled trials (Kapp P, Boutron I et al., BMC Med., 2022)
Read this article - Interventions for the treatment of COVID‐19: a living network meta‐analysis (Boutron I et al, Protocol, Cochrane Library)
Read this article - Interventions for the prevention and treatment of COVID‐19: a living mapping of research and living network meta‐analysis(Boutron I et al, Protocol, Cochrane Library)
Read this article - Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study (Oikonomidi T et al, BMC Medicine)
Read this article - metaCOVID: An R-Shiny application for living meta-analyses of COVID-19 trials (Evrenoglou T, medRxiv, 2021)
Read this article - Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19 (Pierre O, Boutron I et al., J Clin Epidemiol., 2021)
Read this article
Click here to read all our Summary of the evidence for treatment of hospitalized COVID-19 patients identified